Algorhythm Holdings, Inc. (RIME) — This stock currently has no analyst coverage. No price targets, ratings, or earnings estimates are available. This is common for preferred shares, warrants, OTC-traded securities, and smaller companies that are not followed by Wall Street analysts.
Les analystes estiment Bénéfice par action (EPS) de $8.00 et chiffre d'affaires de $0.04B pour le prochain exercice fiscal.
Historique du Bénéfice par action (EPS): 2024: réel $-2.56 vs est $8.00 (manqué -132%). 2025: réel $-6.41 vs est $-5.18 (manqué -23.7%). Précision des analystes: 0%.
Estimations du BPA — RIME
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$2.56
vs Est $8.00
▼ 412.9% off
2025
Actual –$6.41
vs Est –$5.18
▼ 19.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.
Estimations du CA — RIME
66%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.023B
vs Est $0.039B
▼ 66.0% off
2025
Actual $0.004B
vs Est $0.005B
▼ 2.5% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
Les autres consultent aussi
